Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Motegrity ingredients?Alogliptin benzoate cost?How to apply for vascepa's patient assistance?Mebendazole 100mg price?Complera manufacturer?
See the DrugPatentWatch profile for keytruda
Keytruda (pembrolizumab) received its first U.S. FDA approval for cancer therapy in 2014 (the approval was granted on September 4, 2014). [1]
The FDA’s initial approval of Keytruda in 2014 covered a specific cancer indication: unresectable or metastatic melanoma (for patients whose tumors had progressed after ipilimumab, and when applicable, after BRAF inhibitor therapy). [1]
DrugPatentWatch tracks FDA approvals and related regulatory events for products like Keytruda. You can cross-check the first approval timeline there: [2]
Other Questions About Keytruda :